Does the media refer more to TEM or LFST?

In the previous week, Tempus AI had 14 more articles in the media than LifeStance Health Group. MarketBeat recorded 30 mentions for Tempus AI and 16 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 0.86 beat Tempus AI's score of 0.63 indicating that LifeStance Health Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tempus AI 6 Very Positive mention(s) 4 Positive mention(s) 13 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive LifeStance Health Group 5 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor LFST or DVA?

In the previous week, LifeStance Health Group had 9 more articles in the media than DaVita. MarketBeat recorded 16 mentions for LifeStance Health Group and 7 mentions for DaVita. DaVita's average media sentiment score of 1.39 beat LifeStance Health Group's score of 0.86 indicating that DaVita is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeStance Health Group 5 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DaVita 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to HNGE or LFST?

In the previous week, LifeStance Health Group had 5 more articles in the media than Hinge Health. MarketBeat recorded 16 mentions for LifeStance Health Group and 11 mentions for Hinge Health. LifeStance Health Group's average media sentiment score of 0.86 beat Hinge Health's score of 0.37 indicating that LifeStance Health Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hinge Health 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral LifeStance Health Group 5 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

LifeStance Health Group (LFST) Competitors

$12.97 -0.03 (-0.23%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$12.98 +0.01 (+0.12%)

As of 09/11/2026 07:59 PM Eastern

Compare

LFST vs. BTSG, FMS, TEM, DVA, and HNGE

Should you buy LifeStance Health Group stock or one of its competitors? LifeStance Health Group's main competitors and comparable companies include BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), Tempus AI (TEM), DaVita (DVA), and Hinge Health (HNGE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does LifeStance Health Group compare to BrightSpring Health Services?

LifeStance Health Group (NASDAQ:LFST) and BrightSpring Health Services (NASDAQ:BTSG) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.

LifeStance Health Group has a beta of 1.22, suggesting that its share price is 22% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.84, suggesting that its share price is 84% more volatile than the broader market.

LifeStance Health Group has a net margin of 3.19% compared to BrightSpring Health Services' net margin of 2.55%. BrightSpring Health Services' return on equity of 16.73% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	3.19%	3.39%	2.33%
BrightSpring Health Services	2.55%	16.73%	5.24%

BrightSpring Health Services has higher revenue and earnings than LifeStance Health Group. BrightSpring Health Services is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42B	3.48	$9.66M	$0.13	99.77
BrightSpring Health Services	$12.91B	0.90	$190.67M	$1.66	35.38

LifeStance Health Group presently has a consensus price target of $12.88, indicating a potential downside of 0.73%. BrightSpring Health Services has a consensus price target of $70.71, indicating a potential upside of 20.39%. Given BrightSpring Health Services' stronger consensus rating and higher probable upside, analysts plainly believe BrightSpring Health Services is more favorable than LifeStance Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	3.10

85.5% of LifeStance Health Group shares are held by institutional investors. 3.5% of LifeStance Health Group shares are held by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, LifeStance Health Group had 10 more articles in the media than BrightSpring Health Services. MarketBeat recorded 16 mentions for LifeStance Health Group and 6 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.12 beat LifeStance Health Group's score of 0.86 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LifeStance Health Group	5 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BrightSpring Health Services	4 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

BrightSpring Health Services beats LifeStance Health Group on 11 of the 17 factors compared between the two stocks.

How does LifeStance Health Group compare to Fresenius Medical Care AG & Co. KGaA?

LifeStance Health Group (NASDAQ:LFST) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than LifeStance Health Group. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42B	3.48	$9.66M	$0.13	99.77
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.93	11.58

In the previous week, LifeStance Health Group had 16 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 16 mentions for LifeStance Health Group and 0 mentions for Fresenius Medical Care AG & Co. KGaA. LifeStance Health Group's average media sentiment score of 0.86 beat Fresenius Medical Care AG & Co. KGaA's score of 0.00 indicating that LifeStance Health Group is being referred to more favorably in the media.

Company	Overall Sentiment
LifeStance Health Group	Positive
Fresenius Medical Care AG & Co. KGaA	Neutral

85.5% of LifeStance Health Group shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 3.5% of LifeStance Health Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

LifeStance Health Group currently has a consensus target price of $12.88, indicating a potential downside of 0.73%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $23.57, indicating a potential upside of 5.42%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than LifeStance Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.55

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to LifeStance Health Group's net margin of 3.19%. Fresenius Medical Care AG & Co. KGaA's return on equity of 9.28% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	3.19%	3.39%	2.33%
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%

LifeStance Health Group has a beta of 1.22, indicating that its stock price is 22% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market.

Summary

LifeStance Health Group beats Fresenius Medical Care AG & Co. KGaA on 10 of the 17 factors compared between the two stocks.

How does LifeStance Health Group compare to Tempus AI?

Tempus AI (NASDAQ:TEM) and LifeStance Health Group (NASDAQ:LFST) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, media sentiment, institutional ownership and risk.

LifeStance Health Group has a net margin of 3.19% compared to Tempus AI's net margin of -17.77%. LifeStance Health Group's return on equity of 3.39% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tempus AI	-17.77%	-50.28%	-10.33%
LifeStance Health Group	3.19%	3.39%	2.33%

In the previous week, Tempus AI had 14 more articles in the media than LifeStance Health Group. MarketBeat recorded 30 mentions for Tempus AI and 16 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 0.86 beat Tempus AI's score of 0.63 indicating that LifeStance Health Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tempus AI	6 Very Positive mention(s)	4 Positive mention(s)	13 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
LifeStance Health Group	5 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Tempus AI has a beta of 3.72, suggesting that its share price is 272% more volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.22, suggesting that its share price is 22% more volatile than the broader market.

LifeStance Health Group has higher revenue and earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tempus AI	$1.27B	8.37	-$245.03M	-$1.44	N/A
LifeStance Health Group	$1.42B	3.48	$9.66M	$0.13	99.77

24.2% of Tempus AI shares are owned by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are owned by institutional investors. 24.3% of Tempus AI shares are owned by company insiders. Comparatively, 3.5% of LifeStance Health Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Tempus AI presently has a consensus price target of $69.33, indicating a potential upside of 17.49%. LifeStance Health Group has a consensus price target of $12.88, indicating a potential downside of 0.73%. Given Tempus AI's higher possible upside, equities analysts plainly believe Tempus AI is more favorable than LifeStance Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tempus AI	2 Sell rating(s)	8 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.43
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73

Summary

LifeStance Health Group beats Tempus AI on 11 of the 17 factors compared between the two stocks.

How does LifeStance Health Group compare to DaVita?

LifeStance Health Group (NASDAQ:LFST) and DaVita (NYSE:DVA) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings, media sentiment and dividends.

DaVita has higher revenue and earnings than LifeStance Health Group. DaVita is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42B	3.48	$9.66M	$0.13	99.77
DaVita	$13.64B	0.85	$746.80M	$12.22	14.86

DaVita has a net margin of 6.05% compared to LifeStance Health Group's net margin of 3.19%. LifeStance Health Group's return on equity of 3.39% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	3.19%	3.39%	2.33%
DaVita	6.05%	-217.63%	5.07%

In the previous week, LifeStance Health Group had 9 more articles in the media than DaVita. MarketBeat recorded 16 mentions for LifeStance Health Group and 7 mentions for DaVita. DaVita's average media sentiment score of 1.39 beat LifeStance Health Group's score of 0.86 indicating that DaVita is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LifeStance Health Group	5 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DaVita	7 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

LifeStance Health Group has a beta of 1.22, indicating that its stock price is 22% more volatile than the broader market. Comparatively, DaVita has a beta of 0.83, indicating that its stock price is 17% less volatile than the broader market.

LifeStance Health Group presently has a consensus price target of $12.88, indicating a potential downside of 0.73%. DaVita has a consensus price target of $233.43, indicating a potential upside of 28.57%. Given DaVita's higher possible upside, analysts clearly believe DaVita is more favorable than LifeStance Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
DaVita	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.57

85.5% of LifeStance Health Group shares are held by institutional investors. Comparatively, 90.1% of DaVita shares are held by institutional investors. 3.5% of LifeStance Health Group shares are held by company insiders. Comparatively, 1.9% of DaVita shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

LifeStance Health Group beats DaVita on 9 of the 17 factors compared between the two stocks.

How does LifeStance Health Group compare to Hinge Health?

Hinge Health (NYSE:HNGE) and LifeStance Health Group (NASDAQ:LFST) are both mid-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.

LifeStance Health Group has higher revenue and earnings than Hinge Health. Hinge Health is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hinge Health	$587.86M	12.20	-$528.26M	$1.28	69.42
LifeStance Health Group	$1.42B	3.48	$9.66M	$0.13	99.77

Hinge Health has a net margin of 15.15% compared to LifeStance Health Group's net margin of 3.19%. Hinge Health's return on equity of 51.60% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hinge Health	15.15%	51.60%	14.16%
LifeStance Health Group	3.19%	3.39%	2.33%

Hinge Health currently has a consensus price target of $101.93, suggesting a potential upside of 14.71%. LifeStance Health Group has a consensus price target of $12.88, suggesting a potential downside of 0.73%. Given Hinge Health's stronger consensus rating and higher probable upside, research analysts plainly believe Hinge Health is more favorable than LifeStance Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hinge Health	1 Sell rating(s)	2 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.83
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73

85.5% of LifeStance Health Group shares are held by institutional investors. 18.9% of Hinge Health shares are held by company insiders. Comparatively, 3.5% of LifeStance Health Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Hinge Health has a beta of 1.38, indicating that its share price is 38% more volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.22, indicating that its share price is 22% more volatile than the broader market.

In the previous week, LifeStance Health Group had 5 more articles in the media than Hinge Health. MarketBeat recorded 16 mentions for LifeStance Health Group and 11 mentions for Hinge Health. LifeStance Health Group's average media sentiment score of 0.86 beat Hinge Health's score of 0.37 indicating that LifeStance Health Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hinge Health	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
LifeStance Health Group	5 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Hinge Health beats LifeStance Health Group on 10 of the 16 factors compared between the two stocks.

Get LifeStance Health Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LFST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LFST vs. The Competition

Export

Metric	LifeStance Health Group	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$4.96B	$9.84B	$7.16B	$12.85B
Dividend Yield	N/A	2.61%	2.57%	11.71%
P/E Ratio	99.78	33.53	274.94	25.33
Price / Sales	3.48	4.89	633.80	90.72
Price / Cash	77.11	24.78	28.42	34.96
Price / Book	3.32	5.29	10.33	6.21
Net Income	$9.66M	$313.45M	$3.50B	$358.54M
7 Day Performance	1.89%	-1.26%	-3.32%	-2.35%
1 Month Performance	6.14%	-1.53%	-0.53%	-3.23%
1 Year Performance	147.99%	58.44%	23.51%	8.79%

LifeStance Health Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LFST LifeStance Health Group	2.7081 of 5 stars	$12.97 -0.2%	$12.88 -0.7%	+148.0%	$4.96B	$1.42B	99.78	10,961	Trending News Analyst Forecast
BTSG BrightSpring Health Services	4.6039 of 5 stars	$62.56 +3.0%	$70.71 +13.0%	+122.0%	$12.38B	$12.91B	37.69	23,500	Positive News
FMS Fresenius Medical Care AG & Co. KGaA	2.1845 of 5 stars	$22.45 -0.9%	$23.57 +5.0%	-10.5%	$12.06B	$19.43B	11.63	1,488
TEM Tempus AI	3.0329 of 5 stars	$64.29 -0.5%	$68.71 +6.9%	-31.7%	$11.60B	$1.27B	N/A	3,800	Trending News Analyst Forecast
DVA DaVita	4.7669 of 5 stars	$179.87 -2.2%	$221.75 +23.3%	+36.4%	$11.48B	$13.64B	14.72	78,000	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LFST) was last updated on 9/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

LifeStance Health Group (LFST) Competitors

LFST vs. BTSG, FMS, TEM, DVA, and HNGE

How does LifeStance Health Group compare to BrightSpring Health Services?

Summary

How does LifeStance Health Group compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does LifeStance Health Group compare to Tempus AI?

Summary

How does LifeStance Health Group compare to DaVita?

Summary

How does LifeStance Health Group compare to Hinge Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LFST vs. The Competition

LifeStance Health Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

LifeStance Health Group (LFST) Competitors

LFST vs. BTSG, FMS, TEM, DVA, and HNGE

How does LifeStance Health Group compare to BrightSpring Health Services?

Which has more risk & volatility, LFST or BTSG?

Is LFST or BTSG more profitable?

Which has higher valuation & earnings, LFST or BTSG?

Do analysts prefer LFST or BTSG?

Do institutionals and insiders believe in LFST or BTSG?

Does the media favor LFST or BTSG?

Summary

How does LifeStance Health Group compare to Fresenius Medical Care AG & Co. KGaA?

Which has better valuation & earnings, LFST or FMS?

Does the media favor LFST or FMS?

Do institutionals & insiders hold more shares of LFST or FMS?

Do analysts rate LFST or FMS?

Is LFST or FMS more profitable?

Which has more risk and volatility, LFST or FMS?

Summary

How does LifeStance Health Group compare to Tempus AI?

Is TEM or LFST more profitable?

Does the media refer more to TEM or LFST?

Which has more volatility & risk, TEM or LFST?

Which has preferable valuation and earnings, TEM or LFST?

Do institutionals & insiders believe in TEM or LFST?

Do analysts rate TEM or LFST?

Summary

How does LifeStance Health Group compare to DaVita?

Which has higher valuation and earnings, LFST or DVA?

Is LFST or DVA more profitable?

Does the media favor LFST or DVA?

Which has more risk and volatility, LFST or DVA?

Do analysts recommend LFST or DVA?

Do institutionals and insiders hold more shares of LFST or DVA?

Summary

How does LifeStance Health Group compare to Hinge Health?

Which has stronger earnings & valuation, HNGE or LFST?

Is HNGE or LFST more profitable?

Do analysts recommend HNGE or LFST?

Do insiders and institutionals believe in HNGE or LFST?

Which has more risk & volatility, HNGE or LFST?

Does the media refer more to HNGE or LFST?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LFST vs. The Competition

LifeStance Health Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools